{"id":199232,"name":"SAREPTA THERAPEUTICS, INC.","slug":"sarepta-therapeutics-inc","state":"CA","country":"United States of America","description":"","totalSpending":6320000,"filings":35,"yearlySpending":[{"year":2018,"income":540000},{"year":2019,"income":930000},{"year":2020,"income":490000},{"year":2021,"income":560000},{"year":2022,"income":630000},{"year":2023,"income":910000},{"year":2024,"income":1020000},{"year":2025,"income":1240000}],"issues":["BUD","HCR","MMM","TAX","SCI","PHA"],"firms":["SAREPTA THERAPEUTICS, INC."],"lobbyists":["DIANE BERRY","STACEY FRISK","CAROLYN HICKEY","KIP PAYNE"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","HOUSE OF REPRESENTATIVES","SENATE","Food & Drug Administration (FDA)","Office of Management & Budget (OMB)","Centers For Disease Control & Prevention (CDC)","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["S.Con.Res. 25 - Senate Budget Resolution\nH.Res. 553 - House Budget Resolution  \nHR 244 - Consolidated Appropriations Act of 2017\nH.J.Res. 123, HR 1370 - Continuing Resolution\nappropriations generally,","Issues: Innovation, Duchenne muscular dystrophy, platform technologies\nPL 114-255 - 21st Century Cures implementation\nS.204 - Right to Try Act of 2017\nS.771 - Improving Access To Affordable Prescripti","Medicaid Drug Rebate Program, coverage, state level implementation, waivers\nH.R. 3921 - Healthy Kids Act\nS. 1827 - Kids Act of 2017","Request support for enforcement of existing law","Communication regarding education and outreach of company; Communication regarding Newborn Screening Saves Lives Reauthorization Act; Communication regarding guidance on Indications and Usage Section "],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}